Pages

Sunday, October 5, 2014

Transplant Plus Native Nephrectomy May Benefit Patients with Polycystic Kidney Disease

Among 143 ADPKD patients (67 who underwent transplantation alone and 76 who also underwent concurrent unilateral native nephrectomy), nephrectomy patients had a greater decrease in the average number of antihypertensive medications at 12, 24, and 36 months follow-up than transplantation-only patients. Nephrectomy patients also experienced greater decreases in defined daily dose of antihypertensives at 12, 24, and 36 months. The study’s findings were presented at the 32ⁿᵈ World Congress of Endourology and highlighted by Renal & Urology News.

No comments:

Post a Comment